Product NDC: | 0003-2570 |
Proprietary Name: | AZACTAM |
Non Proprietary Name: | AZTREONAM |
Active Ingredient(s): | 2 g/1 & nbsp; AZTREONAM |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0003-2570 |
Labeler Name: | E.R. Squibb & Sons, L.L.C. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050580 |
Marketing Category: | NDA |
Start Marketing Date: | 20100401 |
Package NDC: | 0003-2570-16 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0003-2570-16) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
NDC Code | 0003-2570-16 |
Proprietary Name | AZACTAM |
Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0003-2570-16) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
Product NDC | 0003-2570 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AZTREONAM |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100401 |
Marketing Category Name | NDA |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | AZTREONAM |
Strength Number | 2 |
Strength Unit | g/1 |
Pharmaceutical Classes | Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient] |